INTRODUCTION Health professionals have great difficulties to establish the adequate and safe time to start breast feeding in preterm infants. There is a need to develop a standardized tool to help health professionals to comprehensively evaluate preterm infant readiness to transition preterm infants' feeding from gastric to oral, and encourage breast feeding practice in neonatal units. AIMS T...

Oral anticoagulants and platelet receptor blockers are widely used in clinical practice with the aim of reducing the risk of thrombotic complications in patients with cardiovascular diseases. Their regular intake and adequate antithrombotic action is vital and this is way numerous assays have been developed for laboratory testing and monitoring of these agents. Available assays can be stratifie...

.............................................................................................. 10

Submit Manuscript | http://medcraveonline.com Abbreviations: DOACs: Direct Oral Anticoagulants; DVT: Deep Venous Thrombosis; PE: Pulmonary Embolus; PBS: Pharmaceutical Benefits Scheme; PD: Pharmacodynamic; PK: Pharmacokinetics; TGA: Therapeutic Good Administration; PCC: Prothrombin Complex Concentrate; PT: Prothrombin Time; aPTT: Activated Atrial Thromboplastin Time; FDA: Food and Drug Administ...

The Helicobacter Pylori infection (HPI) has emerged as one of the most commonchronic bacterial infections worldwide. main ways to transmit HPI is direct contact from personto-person by oral-to-oral or fecal–to oral and crowded living conditions.

The introduction of direct oral anticoagulants (OACs) for the treatment and prevention of thromboembolic disease represents a shift from the traditional vitamin K antagonist-based therapies, which have been the mainstay of treatment for almost 60 years. A challenge for hospital formularies will be to manage the use of direct OACs from hospital to outpatient settings. Three direct OACs-apixaban,...

Although direct oral anticoagulants do not need laboratory testing for dose adjustment, there are instances when laboratory measurement of the drug anticoagulant effect may be useful. They include before initiation of treatment, before surgical or invasive procedures, on the occasion of hemorrhagic or thrombotic events, and whenever immediate reversal of anticoagulation is needed. Choice of tes...

oral health problems, among the most prevalent comorbidities related to addiction, require more attention by both clinicians and policy-makers. our aims were to review oral complications associated with drugs, oral health care in addiction rehabilitation, health services available, and barriers against oral health promotion among addicts. drug abuse is associated with serious oral health proble...

OBJECTIVE To present the chemistry, pharmacology, and pharmacokinetics of ximelagatran, an oral direct thrombin inhibitor (DTI), and to review available comparative clinical trial data evaluating its efficacy and safety relative to other antithrombotic agents in the prevention and treatment of thromboembolism. DATA SOURCES A search of the PubMed and Cochrane databases (1995-August 2004), supp...

Edoxaban is an oral direct factor Xa inhibitor that is currently undergoing investigation in phase III clinical trials for the prevention of stroke in patients with atrial fibrillation (AF) and for the prevention and treatment of venous thromboembolic events (VTE). Factor Xa is an attractive target for anticoagulant treatment, as it is the primary and rate-limiting source of amplification in th...